骨髓增生异常综合征合并肺毛霉病患者药学监护一例

Pharmaceutical care for a case of pulmonary mucormycosis with myelodysplastic syndrome

毛霉菌病疗程长,药物的不良反应及相互作用较多,全程药学监护有助于促进临床合理用药,保证治疗的安全。临床药师对1例骨髓增生异常综合征合并肺毛霉菌感染患者实施全程化药学监护,分析毛霉菌感染危险因素,提出药学建议,协助医师制订个体化给药方案,在合适的时机开启去铁治疗,避免了药物相互作用和不良反应发生。

Treatment course of mucormycosis would last for a long time and there may be a lot of ADRs and drug interactions.Pharmaceutical care is helpful in promoting rational clinical drug use and ensuring the medication safety of patients.Clinical pharmacists gave pharmaceutical care to a pulmonary mucormycosis patient with myelodysplastic syndrome(MDS).The advice was suggested to prevent from drug interactions and adverse effects.The most suitable regimen was selected through individualized drug therapy.Moreover,drug interactions were avoided through individualized drug therapy.